Dr. Peter Rinck, PhD[email protected]Clinical NewsUse of English in post-Brexit worldEnglish remains by far the dominant language in medicine and science, but political changes underway in the European Union and the U.S. may reduce the level of Anglo-American control across the globe. The Maverinck investigates in his latest column.June 27, 2017Clinical NewsSpreading the news: Science and the mediaFake news and alternative truths are hot topics right now, but they're not new, and lies and disinformation are as old as mankind, writes the Maverinck. He considers what can be done to maintain and protect the truth in radiology and science in general.May 2, 2017Clinical NewsGadolinium contrast: Farewell to well-known brandsThe long wait is over for the European Medicines Agency (EMA) investigation into gadolinium contrast agents. Its noncommittal verdict punishes all manufacturers, though some are given a sweetener, but it does not shed a complimentary light upon EMA, writes the Maverinck.March 14, 2017Clinical NewsNew kid in town shakes up MR contrast useThe "gadolinium story" is the talk of the town, but a completely different group of contrast agents for MRI is just around the corner and well worth a close look, writes the Maverinck in his latest column.February 14, 2017Clinical NewsDebacles mar big science and fMRI researchFunctional MRI (fMRI) was one of the most promising research techniques for and beyond neuroimaging, but have hundreds of millions of euros of research grants been wasted? Dr. Peter Rinck, PhD, investigates in his latest column.November 15, 2016Clinical NewsMR safety: Why we may not need a 20T scannerThe mere concept of ultrahigh-field MRI is debatable because there will be problems and risks beyond heat deposition and deafening noise, writes the Maverinck in his latest column. All exams above 2 tesla should be viewed as experimental, not clinical.September 20, 2016Clinical NewsNewspeak in radiologyDo radiologists communicate with themselves and their colleagues in such a way that everybody gets the same message? Perhaps not. New nomenclature gets coined by some ignoramuses that is plainly wrong, the Maverinck contends. Read more about his thoughts on language in this latest column.August 14, 2016Clinical NewsSmartphones don't upgrade your brainSmartphones are toys or ersatz shrines we pray to, the Maverinck wrote in 2012. He revisits the topic and shares his latest thoughts on these ubiquitous devices. How can you deal with a hopelessly hooked patient?July 19, 2016Enterprise ImagingDatarrhea: The great data revolutionMany opinion makers in medical imaging have accepted as gospel that the future of imaging medicine is digital and that one has to collect all kinds of data available to process and reprocess. They try to sell the concept that images are data. In his latest column, the Maverinck tries to demystify this "datarrhea."June 7, 2016Clinical NewsScience publishers: The beginning of the end?In his latest column, the Maverinck takes on scientific journals, specifically vanity or subsidy publishers that make authors pay for publication of their articles. Does this spell the beginning of the end for science publishers?April 26, 2016Previous PagePage 4 of 10Next PageTop StoriesArtificial IntelligenceBeyond the algorithm: Embedding AI into imaging workflowsIntegrating AI into workflow is the defining factor that determines whether a tool delivers real value or fades into irrelevance, writes market analyst Umar Ahmed.Radiology EducationUkrainian radiologists train, collaborate throughout warMRICE MRI-based radiomics model captures DEB TACE-induced tumor changesCTImaging casts new light on war injuriesWomens ImagingHybrid AI reading shows success in breast cancer screening
